Page 7 - Benchmark Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

VaxCorps Announces Massive Expansion of Vaccine Research Network Share Article VaxCorps, a U.S. and Canada based integrated research organization specializing in the conduct of vaccine trials, today announced the expansion to the network of three new partners—Coastal Carolina Research Center, Elligo Health Research, and Javara Research—adding additional vaccine capabilities and capacity required to support its rapid business growth. AUSTIN, Texas (PRWEB) May 04, 2021 VaxCorps’ expansion includes more vaccine companies than...

With millions of adults fully vaccinated, many families are wondering when their children will be able to receive the same protection.Benchmark Research is currently looking for participants in the Sacramento area to join their trial for the Novavax pediatric vaccine.The company says it's important to have a diverse pool of vaccine trial participants. “We have to demonstrate to the authorities that it will induce a good immune response. That this younger group won’t have a more significant adverse experience such as sore arms and things like that," said Cynthia Dukes with Benchmark R...

Local clinical company Benchmark Research is looking for up to 250 volunteers for a trial with the Medicago vaccine.

Despite the Covid-19 health crisis impacting significantly on the lifting industry, Lifting Equipment Engineers Association (LEEA) Sector Benchmark Research reveals optimism for the post-pandemic future

Plant-based COVID-19 vaccine trial needs volunteers in our area Dr. Brian Ward said people confuse the plant with nicotine tobacco but it is actually a distant cousin. Author: Daranesha Herron (KVUE) Updated: 7:15 PM CDT April 1, 2021 AUSTIN, Texas — A plant-based COVID-19 vaccine is inching closer to emergency use authorization by starting trials around the country, including Austin.  Three COVID-19 vaccines received emergency use authorization in the U.S., and a couple more are starting to work through phase three of clinical trials to join the list.  Med...